Pharmalucence

Form 483 issued June 29, 2016 · Bedford, Massachusetts

Inspection
Jun 13 – Jun 29, 2016
Observations
4
Pages
9
FEI number
1219718

In short: On June 29, 2016, FDA issued a Form 483 with 4 observations to Pharmalucence in Bedford, Massachusetts (FEI 1219718) after an inspection that ran Jun 13 – Jun 29, 2016. The investigators were Erik W. Koester and Robert J. Martin. Most observations concern quality system.

At a glance

Observations span 1 system, led by quality system.

Quality system2
Other2

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch…

  2. 02

    An NDA-Field Alert Report was not submitted within three working days of receipt of information concerning…

  3. 03

    The responsibilities and procedures applicable to the quality control unit…

  4. 04

    /2016( Wed),6/23/2016(Thu),6/27/2016(Mon),6/28/2016(Tue),6/29/2016(…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Pharmalucence?

FDA listed 4 observations on this Form 483, mostly about quality system. The opening words of each observation are shown on this page.

Who inspected Pharmalucence?

Erik W. Koester and Robert J. Martin are named on this Form 483, for the inspection of Jun 13 – Jun 29, 2016. Each investigator has a profile showing what they cite most.

When was Pharmalucence inspected by FDA?

The inspection ran Jun 13 – Jun 29, 2016, and the Form 483 is dated June 29, 2016.

How do I get the full Form 483 for Pharmalucence?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free